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Author Manuscript

Self-efficacy has repeatedly been demonstrated to be a robust predictor of outcomes in the
treatment of marijuana use disorders. It is not clear, however, how increases in confidence in
ability to refrain from use get translated into actual improvements in drug-related outcomes.
Marlatt, among others, viewed the acquisition and use of coping skills as the key to behavior
change, and self-efficacy as a cognitive state that enabled coping. But that model of behavior
change has not been supported, and few studies have shown that the effects of self-efficacy are
mediated by coping or by other processes. The current study combined three marijuana treatment
trials comprising 901 patients to examine the relationships between self-efficacy, coping, and
potential mediators, to determine if the effects of self-efficacy on outcomes could be explained.
Results of multilevel models indicated that self-efficacy was a strong predictor of adaptive
outcomes in all trials, even when no active treatment was provided. Tests of mediation showed
that effects of self-efficacy on marijuana use and on marijuana-related problems were partially
mediated by use of coping skills and by reductions in emotional distress, but that direct effects of
self-efficacy remained largely unexplained. The results are seen as supportive of efforts to
improve coping skills and reduce distress in marijuana treatment, but also suggest that additional
research is required to discover what is actually occurring when substance use changes, and how
self-efficacy enables those changes.
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The term self-efficacy refers to having confidence in one’s ability to perform a given
behavior in a given circumstance. This concept has become one of the most influential
constructs in the addictions literature. In study after study self-efficacy has emerged as one
of the most, if not the most, powerful predictors of treatment outcome (Kadden & Litt,
2011). In some sense, however, these results are not entirely explanatory. It is not clear, for
example, just how increased “confidence” translates into improved outcomes. The purpose
of the present study was to determine whether some other, more tangible, variables might
help account for the effects of self-efficacy in a large sample of patients in treatment for
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marijuana dependence. That is, we sought to determine whether self-efficacy worked by
simply enhancing “willpower,” or by some other means, particularly by increasing the
likelihood of using coping resources, or “skill power,” as discussed by Marlatt (e.g., Marlatt
& Gordon, 1985). A better understanding of what is being changed when we enhance selfefficacy may help us improve our treatments.

Author Manuscript

Although initially intended as a highly situation-specific cognitive variable, over time the
concept of self-efficacy has been interpreted more generally, and is now commonly treated
as a state variable (rather than a situation-specific one). In any case, the basic relationship
posited by Bandura (1977) is still presumed to be true: self-efficacy expectancies will
determine “whether coping behavior will be initiated, how much effort will be expended,
and how long it will be sustained in the face of obstacles and aversive experiences” (p. 191).
Bandura’s conceptualization of how self-efficacy gets translated into behavior change
suggested certain mediational constructs, namely coping behavior(s), and persistence, or
motivation.
In much research in the addictions, however, potential mediators of the effects of selfefficacy seem to be left out. It is often not clear how self-efficacy gets translated into
reduced substance use or prevention of relapse, a gap in our knowledge also noted by others
(e.g., Maisto, Connors, & Zywiak, 2000). In recent literature regarding all areas of behavior
change, including addictions, it seems to be assumed that simply the possession of selfefficacy is itself sufficient to alter behavior. In an earlier review of self-efficacy in the
addictions (Kadden & Litt, 2011) we made note of research demonstrating that self-efficacy
could act as a predictor and/or a mediator of outcomes. But no studies were found that
identified true mediators of the effects of self-efficacy itself.

Author Manuscript

Since the Kadden and Litt (2011) review, other papers on self-efficacy have appeared, but
most do not mention mediators of self-efficacy. For example, with respect to drinking,
Witkiewitz, Donovan, and Hartzler (2012) found that self-efficacy significantly mediated
the effects of drink refusal skills training on drinking outcomes, and Sugarman, Kaufman,
Trucco, Brown, and Greenfield (2014) found that self-efficacy mediated the impact of
alcohol severity on drinking outcomes. In a related area, Schuck, Otten, Kleinjan, Bricker,
and Engels (2014) found that self-efficacy mediated the effect of smoking cessation
counseling on abstinence at 12-months follow-up. With specific reference to cannabis,
Connor, Gullo, Feeney, Kavanagh, and Young (2014) reported that refusal self-efficacy
fully mediated the relationship between negative marijuana outcome expectancies and
decreases in weekly consumption, and partially mediated the impact of positive expectancy
on consumption.

Author Manuscript

However, none of these reports make any mention of mediation of the effects of selfefficacy. We found only two substance-abuse related papers in which mediation of selfefficacy is mentioned at all. A study on alcohol treatment by our group did posit a
relationship between increases in coping self-efficacy and increases in cognitive and
behavioral coping to predict reductions in drinking at posttreatment (Litt, Kadden, Cooney,
& Kabela, 2003). Formal tests of mediation were not performed, however. Collins,
Witkiewitz, and Larimer (2011) determined that intention to engage in risky drinking on the
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part of college students mediated the effects of self-efficacy on risky drinking. However, this
was a cross-sectional analysis, and the possibility that self-efficacy might have mediated the
effect of intentions on drinking was not tested. Nor is it clear that the notion of “intentions”
is any more explanatory than self-efficacy itself in terms of behavior change.
One study in which our group participated found that self-efficacy acted on outcomes in part
through enhancing coping (Litt, Kadden, Stephens, & Marijuana Treatment Project Research
Group, 2005). Structural equation models indicated that self-efficacy was strongly related to
coping change, and that both were related to decreasing marijuana use over time. Measures
of mediation were not significant, however, and even with coping in the model, self-efficacy
was strongly and independently predictive of outcome over time.

Author Manuscript

Although the research in this area is sparse, there are a couple of avenues by which selfefficacy may influence substance use outcomes. We have already touched on the idea that
high self-efficacy theoretically should translate into increased acquisition and use of coping
skills. In addition, however, we might expect self-efficacy to have effects on other processes
that influence use of marijuana. One of these processes is emotional distress.

Author Manuscript

Bandura (1982; 1986) theorized that those high in self-efficacy for a task would persevere,
and would thus be more likely to achieve their goals, leading to improvements in mood.
Improvement in distress levels would be the result of reinforcement for actual or perceived
accomplishments. Other studies have indicated, however, that coping self-efficacy measured
as a trait variable was predictive of less short and long-term distress following a natural
disaster (Benight et al., 2015), and less fatigue and depression in cancer patients (Phillips &
McAuley, 2013). Thus self-efficacy per se, that is, the sense of increased confidence itself,
appears to be protective against distress, and may perhaps enhance positive mood. Given
that emotional coping is a major motive for use of marijuana (Bonn-Miller, Zvolensky, &
Bernstein, 2007; Zvolensky et al., 2007), it is likely that decreases in psychological distress
would facilitate reductions in use.
To evaluate some of the possible mediators of self-efficacy on outcomes we combined three
large samples of adult marijuana users in treatment. Mediation analyses were then conducted
in which marijuana abstinence self-efficacy at the posttreatment time point was treated as
the independent variable, marijuana use and marijuana problems measures were treated as
outcomes, and measures of coping and psychological distress were treated as mediators.

Author Manuscript

Finally, some research has suggested that self-efficacy may develop and function differently
for men and women. Davis and Jason (2005), for example, reported that women drinkers in
treatment, but not men, tended to derive abstinence self-efficacy from sober social supports.
Schunk and Lilly (1984) noted that women and girls are less likely than men to attribute
performance successes to personal effort. To the extent that this is true women may not only
report lower self-efficacy in abstinence contexts, but their self-efficacy reports may not
translate as clearly as men’s into performance accomplishments (i.e., reducing substance
use). Therefore, as a final exploration of the effects of self-efficacy on outcomes we
examined the extent to which patient gender might have moderated any mediation
relationships that emerge in these analyses..
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Method
Participants

Author Manuscript

Participants were 901 patients treated in one of three clinical trials for marijuana
dependence. All participants were recruited from the community through the use of
newspaper and/or radio advertisements offering outpatient treatment. In the first trial, the
Marijuana Treatment Project (MTP; Stephens, Babor, Kadden, Miller, & The Marijuana
Treatment Project Research Group, 2002), participants were recruited from the greater
metropolitan areas of Seattle, Hartford, and Miami. For the second and third trials that
provided data for this study (MTP2 and MTP3), participants were recruited only from the
greater Hartford area. For all trials, participants were eligible if they were 18 years of age or
older and met DSM-IV diagnostic criteria for cannabis dependence during the 90 days prior
to intake. Persons were excluded if they were dependent on other drugs (except nicotine) or
on alcohol, unwilling to accept random assignment to treatment, currently receiving therapy
or regularly attending a 12-Step group, or unable to provide a contact person who would be
able to locate the individual for future follow-ups. Table 1 shows the demographic and
baseline characteristics of the samples in the three marijuana treatment trials.
Treatments Received

Author Manuscript

All patients randomized to treatment in each of the three trials were included in these
analyses, even if they did not receive active treatment. The reasons for this are that all
patients in these trials, regardless of treatment assignment, (1) had the experience of being in
a treatment trial, (2) for the most part improved from pre- to posttreatment, and (3) preposttreatment changes in substance use reported by all of the patients in these trials were
subject to similar effects of self-efficacy and mediation of self-efficacy effects. This was
expected to be true even for those in the delayed treatment control condition in MTP, during
the period in which they received no active treatment. In short, we were more interested in
the processes determining treatment trial-related gains than in specific treatment effects.

Author Manuscript

MTP recruited 450 patients who were assigned randomly to either a 2-session motivational
enhancement therapy (MET) condition, a 9-session treatment that combined MET with CBT
and case management, or delayed treatment in which participants completed assessments at
baseline and at the 4- and 9-month follow-ups, but received no treatment during the first 4
months. In MTP2, 238 participants were randomly assigned to one of four conditions: (1)
Case Management that focused on life issues such as occupational, social, psychiatric, or
educational concerns, (2) MET+CBT, which included the teaching of skills for coping with
high risk situations, (3) Contingency Management (ContM) which provided reinforcement
(vouchers redeemable for goods and services) contingent upon submitting drug-free urine
samples; and (4) MET+CBT+ContM.
MTP3 was designed to test the efficacy of enhancing the completion of between-session
homework assignments as a means of increasing coping skills acquisition. Participants
(N=213) were assigned randomly to (1) MET+CBT+ContM-Homework, which paralleled
MET+CBT treatment but with added delivery of reinforcements contingent upon engaging
in homework activities, (2) MET+CBT+ContM-Abstinence, which was structured like the
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first treatment but with reinforcements delivered contingent upon submitting drug-free urine
samples, or (3) Case Management, an active control condition.
Measures and Instruments
Patients in all three trials were administered a common set of instruments that were used in
the present study to evaluate the mediation of self-efficacy on marijuana-related outcomes.
Posttreatment assessments were administered at the completion of the treatment period in
each trial: at 4 months in MTP, and at 2–3months in the other two trials. Other follow-up
periods occurred at 4–5 months, 8–9 months, 11 months (for MTP2 and MTP3), and 14–15
months post-intake. Marijuana outcomes at 8–9 months were used as the dependent
variables in mediation analyses. Analyses of overall effects of self-efficacy on outcomes
were conducted on all time points (see below).

Author Manuscript

Dependent variables: Marijuana use and marijuana-related problems—
Marijuana use was assessed using a Time Line Follow-Back (TLFB) interview (Sobell &
Sobell, 1992) to reconstruct cannabis use for each of the 90 days prior to the baseline and
follow-up interviews. Urine specimen results and collateral informant interview data both
suggested that participants did not systematically underreport their use of marijuana
(Marijuana Treatment Project Research Group, 2004). Two marijuana use variables were
computed: continuous abstinence during each assessment period (yes – no), and proportion
of days abstinent in the period (PDA). These variables did not take into account use of
alcohol or drugs besides marijuana.

Author Manuscript

The Marijuana Problem Scale (MPS; Stephens, Wertz, & Roffman, 1993) is a 20-item selfreport inventory that assesses negative social, occupational, physical, and personal
consequences associated with cannabis use in the previous 90 days. Each item is scored on a
three-point scale with 0=No problem, 1= Minor problem, and 2= Major problem. A MPS
problem score is calculated by summing the items. In our samples the scale had an internal
reliability α = .81.

Author Manuscript

Independent variable: Marijuana abstinence self-efficacy—Self-efficacy for
marijuana abstinence was assessed using a 20-item questionnaire developed by Stephens,
Wertz, and Roffman (1993; 1995). Participants were asked to indicate on a 7-point scale
their confidence in their ability to resist the temptation to smoke in a variety of interpersonal
and intrapersonal situations. In our samples the internal consistency reliability exceeded α
= .90. Although the Marijuana Self-Efficacy Scale was administered at various times in the
three trials, it was only consistently administered at pretreatment and posttreatment. Use of
these time points allowed us to capture pre-posttreatment changes in self-efficacy, and to
treat posttreatment self-efficacy (measured at months 2–4 depending on the trial) as the
independent variable (IV) in the analyses of outcomes.
Potential mediating variables—Mediating variables were assessed at 4–5 months post
intake. Coping was measured using the Coping Strategies Scale (CSS; Litt et al., 2005). The
CSS is comprised of 48 items intended to tap potential coping strategies that might be used
by patients to remain abstinent. Respondents rate the frequency (from 1 = never to 4 =
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frequently) of using specific strategies in the previous 3 months. Although a number of
subscales have been created for the CSS, the most reliable and predictive of the CSS scales
is the Total Coping score, calculated by taking the mean across all 48 items (Litt, Kadden, &
Tennen, 2012). The internal reliability of the CSS Total Coping score exceeded α=.90
across all trials. The CSS Total Coping score at 4–5 months was used as the coping
mediating variable in the analyses that follow.

Author Manuscript

Psychological distress in the MTP study was assessed with the Beck Depression Inventory
(BDI; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961). The BDI is among the best known
measures of depressive symptoms. It consists of 21 items, utilizing a 0 to 3 scale to rate
intensity of symptoms including depressed mood, pessimism, sense of failure,
neurovegetative signs, and suicidal thoughts. Items are summed to give a total depression
score (internal reliability α =.86). The Brief Symptom Inventory (BSI; Derogatis &
Melisaratos, 1983), a widely-used 53-item self-report scale, was used to assess gross
changes in psychological functioning and distress in the MTP2 and MTP3 trials. The BSI
total score was used as a Global Severity index. It was administered at baseline and at all
follow-ups in MTP2 and MTP3. The Global Severity score had an average internal
reliability of α =.95. For both the BDI score and the BSI score the posttreatment values were
used as the mediating variables.

Author Manuscript

A related construct, psychiatric problem severity, was assessed in all trials with the
Addiction Severity Index (5th edition; McLellan et al., 1992) psychiatric severity subscale.
The ASI is a semi-structured interview designed to address seven potential problem areas in
substance-abusing patients: medical status, employment and support, drug use, alcohol use,
legal status, family/social status, and psychiatric status. The instrument gathers information
on recent (past 30 days) and lifetime problems in all of the problem areas. The psychiatric
severity subscale assesses occurrence of severe instances of psychiatric disturbance,
treatment for those problems, and disturbance caused by them. ASI psychiatric severity
scores that were collected at 4–5 months served as mediating variables in the present study.
Data Analysis

Author Manuscript

All analyses were conducted using SPSS, version 20.0 (IBM Corp., 2011). Effects of selfefficacy on outcomes across trials over time were examined to establish the general
predictive ability of the construct. Overall treatment effects, and effects of self-efficacy over
the three trials, were examined using multilevel linear models with maximum likelihood
estimation for continuous dependent variables (PDA and MPS), employing Satterthwaite’s
approximation of degrees of freedom (Satterthwaite, 1946). In the multilevel models all
effects were treated as fixed. Fixed effects were specified because the use of these provided
better fit to the data (as measured by AIC) than when random effects were included, and
because we had no hypotheses about relationships between predictors and outcomes over
time differing by subjects. A strength of these analyses is that subjects’ slopes over time are
allowed to vary independently. Additionally, Subjects was treated as a random effect,
allowing the intercept to vary randomly across participants (Hayes, 2006).
A generalized estimating equations (GEE) procedure with a binary logistic response model
was used to evaluate abstinence (yes –no) for each follow-up period over time. For each
Psychol Addict Behav. Author manuscript; available in PMC 2015 September 29.
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analysis the level 1 variable was time in months since the baseline assessment, out to 14–15
months. Level 2 variables were Trial (collapsed over individual treatments), and both
baseline and posttreatment marijuana abstinence self-efficacy. We did not distinguish
between intervention and control conditions because, as discussed above, we were not
interested in treatment effects per se.

Author Manuscript

Mediation analyses were conducted to determine if attributions of self-efficacy got
translated into cognitive, affective and/or behavioral changes that might directly influence
marijuana-related outcomes. For these analyses we used outcome variables at 8–9 months
post-intake as the dependent variables. This time point was chosen based on the observation
that all marijuana outcomes appeared to have plateaued by this time point, and thus provided
a reasonable representation of treatment-period effects. This extended time point,
approximately 4 months after the assessment of the mediator variables, would also allow us
to draw conclusions about temporal causality in the models.
As indicated above we were primarily interested in the possible mediating effects of coping,
but also examined changes in measures of emotional distress as potential mediators of selfefficacy effects. Mediation analyses were conducted using Hayes’ SPSS macro PROCESS
(Hayes, 2012; Hayes, 2013), with 1,000 bootstrap resamplings. The procedure examines the
effect of the independent variable (marijuana abstinence self-efficacy in these analyses) on
the mediator (e.g., coping score at 4–5 months; the “a path”), the effect of the mediator on
the outcome (the “b path”), and the indirect effect of self-efficacy on the outcome through
its effects on the mediator (the “c′ path”).

Author Manuscript

Marijuana abstinence self-efficacy at intake, and mediator variable scores at intake, were
included as covariates in these analyses to help adjust for individual differences in intake
levels and the effects of treatment. The scores of the outcome variables, assessed at intake,
were tested in initial models as covariates, but were non-significant contributors, and were
thus not included in the mediation models reported here. The basic mediation model is
shown in Figure 1. The inclusion of the baseline values of the mediator variables as
covariates had the effect of treating the mediator as a residualized change variable (i.e.,
posttreatment value corrected for baseline level). This method has the advantage of
characterizing change without the problem of bias of initial (baseline) values (Cronbach &
Furby, 1970; Hand & Taylor 1987). The effect of this approach is to test variables at followup while keeping initial values constant across subjects, thus getting a good estimate of
changes occurring during a treatment interval.

Author Manuscript

The size and significance of the indirect effect was estimated, and tested using Sobel tests,
yielding a z-test for conventional significance (Sobel, 1982). Additionally, point estimates
and 95% bias-corrected bootstrapped confidence intervals (CI) were estimated. The indirect
effect is considered statistically significant if the corresponding bootstrapped CI does not
contain zero.
If more than a single mediator variable was found to be significant, tests of multiple
mediation were conducted that included all those variables that showed significant
mediating properties (significant indirect effects). The occurrence of multiple mediators
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would suggest that the independent variable, self-efficacy, exerts its influence on outcomes
via multiple pathways. Finally, all single mediation models were tested for moderation by
patient gender.

Results
Examination of Overall Treatment and Self-Efficacy Effects

Author Manuscript

Mixed model analysis of PDA yielded a non-significant effect for treatment trial, and
significant effects for Time [F(1, 3528.81) = 484.45; p < .001], and for both baseline
[F(1, 752.23) = 8.05; p < .005] and posttreatment [F(1, 743.06) = 341.06; p < .001] values of
marijuana abstinence self-efficacy respectively. Analysis of MPS yielded similar results,
with a non-significant effect for Trial, and significant effects for Time [F(1, 3065.77) =
612.65; p < .001], and for both the baseline [F(1, 743.58) = 34.97; p < .001] and posttreatment
values of self-efficacy [F(1, 732.51) = 92.70; p < .001]. GEE analysis of abstinence status over
time indicated no significant between-Trial effect, a significant effect for Time (Wald
χ2=90.36; p < .001), no significant effect for baseline self-efficacy, and a significant effect
for posttreatment self-efficacy (Wald χ2=343.10.36; p < .001).

Author Manuscript

The influence of Time and marijuana self-efficacy on outcomes is illustrated in Figure 2.
Outcomes are plotted by Trial and Time since baseline, and by self-efficacy level, high
versus low. Self-efficacy level was determined by taking the median posttreatment selfefficacy score adjusted for baseline, and subtracting or adding 1 SD for thresholds for low
and high levels. Medians and standard deviations were Trial-specific. As seen in the figure,
all patients in all trials (in all treatment conditions) experienced gains from baseline to the 4–
5 months point, but patients high in self-efficacy reported significantly better outcomes over
time.
Mediation of self-efficacy effects on outcomes
The results of the mediation analyses are shown in Table 2. As seen in the table, the
influence of self-efficacy on PDA at months 8–9 was significantly mediated through its
effects both on the CSS coping variable and on BDI depression score. Examination of the A
path coefficients indicated that self-efficacy was predictive of increased coping and
decreased BDI scores, which in turn were predictive of higher PDA (B paths). The effect of
coping score was non-trivial, accounting for over 11% of the effect of self-efficacy on PDA.

Author Manuscript

Effects of self-efficacy on abstinence at 4–5 months were mediated by the CSS coping
score, such that higher self-efficacy resulted in higher coping scores, which in turn led to
greater levels of abstinence. The indirect effect of self-efficacy on abstinence through CSS
score was only 7.3% however. In contrast to the analysis of PDA, no other variable emerged
as a significant mediator of self-efficacy on abstinence outcome.
The effects of self-efficacy on MPS score at months 8–9 were mediated by several variables
measuring psychological or emotional distress: BDI score or BSI score (depending on the
trial), and the ASI Psychiatric Severity score. Increases in self-efficacy from baseline to the
posttreatment time point were associated with decreases in all of the distress measures.
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Decreases in distress were in turn associated with decrease in MPS scores at 8–9 months.
Coping score, however, failed to mediate the effect of self-efficacy on the MPS score.
Multiple mediators of self-efficacy effects on outcomes
Table 3 summarizes tests of multiple mediation of self-efficacy effects on PDA and MPS
scores. As seen here, both CSS score and BDI score contributed significantly and
independently to the mediation of self-efficacy effects on PDA. They did not totally account
for the effects of self-efficacy, however. Even accounting for both CSS and BDI scores, the
direct effect of abstinence self-efficacy on PDA was significant, and large (B= .006; se=.
001; β= 0.485; t=9.722; R2 = .16; p < .001).

Author Manuscript

When multiple mediators were examined for the effects on MPS score, the BDI score again
emerged as a significant mediator of self-efficacy effects. ASI psychiatric severity score
dropped out in this analysis, however, probably due to its high correlation with BDI (r=.50;
p < .001). Again, the addition of two mediating variables could not account for the total
effect of self-efficacy on MPS scores. The direct effect of abstinence self-efficacy on MPS
remained significant (B= −0.059; se=0.011; β= −.293; t=−5.16; R2= .07; p <.001).
Moderation of mediation effects by patient gender
Patient gender was entered as a moderator in each of the single mediation models described.
In none of these models did gender emerge as a significant moderator of any of the
mediation relationships. In short, men and women appeared very much alike in the extent to
which their reports of self-efficacy predicted outcomes, and the degree to which coping or
distress variables mediated the relationship between self-efficacy and outcomes.

Author Manuscript

Discussion

Author Manuscript

The results demonstrate once again that self-efficacy plays a significant role in the
prediction of treatment program-related gains in substance use. These gains occurred even in
a waiting–list control group (in MTP, Trial 1 in this study). Regardless of treatment
condition, those who increased most in self-efficacy had better outcomes that persisted for
more than a year. The results also indicated that part of the effect of self-efficacy, at least on
marijuana usage, was accounted for by increases in the use of coping skills, and to a smaller
degree by decrease in emotional distress. These results are consistent with social learning
theory in that increased self-efficacy should result in greater persistence at efforts to abstain,
and in lower distress, as personal and treatment-related goals are met. These gains in
persistence and reductions in distress should in turn lead to lower drug use and fewer
problems related to use.
Our results also indicated, however, that only a portion of the effect on outcomes accounted
for by self-efficacy could be explained by improvements in coping and distress. Indeed, in
terms of PDA, the total coping score accounted for only about 11% of the total effect
explained by self-efficacy (see Table 2). Baron and Kenny (1986) suggested that, at least in
the behavioral sciences, complete mediation of effects would be rare, because there are so
many variables that account for human behavior. In the present study it would seem that we
are missing additional variables that might explain how increases in confidence get
Psychol Addict Behav. Author manuscript; available in PMC 2015 September 29.
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translated into reduced use of marijuana. Use of coping skills was even a poorer predictor of
90-day abstinence than of PDA, indicating that even more missing variables may be
implicated in producing abstinence rather than reduction of use. One conclusion is that most
of the things that people are doing differently as a result of increased self-efficacy were not
captured by our assessments.

Author Manuscript

In terms of accounting for marijuana-related problems, the results were somewhat more
enlightening. Self-efficacy was a significant predictor of problems, and a sizable part of that
effect was accounted for by reductions in distress, especially depression-related symptoms
(See Table 3). This is not entirely surprising, given that the MPS is made up of several items
reflecting emotional distress, including feelings of low self-esteem and feeling bad about
using drugs. The correlations of the MPS score with BDI and BSI scores were r=.53 and r=.
25 respectively. It is notable that coping score did not mediate the effects of self-efficacy on
marijuana problems at the 8–9 month follow-up. It appears that skills that were intended to
be used to help reduce use of marijuana did not translate into reduction of social,
occupational, and physical problems later on. This may not be entirely surprising; a quick
glance at our data indicate that marijuana use and problems only share at most about 20% of
their variance.
Our examination of possible moderation of the mediating relationships by patient sex was
also interesting. Our failure to find a moderated mediation suggest that women and men are
much alike in their perceptions of self-efficacy, and in the ways in which self-efficacy,
coping and distress operate to help determine substance use outcomes.

Author Manuscript

Despite the incomplete nature of the mediation of self-efficacy on outcomes, it is valuable
that at least some mediation effect was found, especially for coping skills. Despite the
promise of a model in which heightened confidence results in increases in coping efforts,
this result has not always been found in previous studies. Although self-efficacy has been
consistently predictive of treatment outcomes, the same has not been true of coping skills.
For one thing, coping skills are often not measured. And even when coping skills are
measured they have often failed to predict outcomes. This has been true in a number of
studies, and not only in studies of marijuana treatment.

Author Manuscript

In a well-known example of the failure of coping skills to predict outcomes, Hawkins,
Catalano, and Wells (1986) found that a skills training intervention for drug users produced
significant improvement in skills related to avoiding drug use, coping with relapse, social
interaction, problem solving, and coping with stress. At a 1-year follow-up, however, despite
evidence of retention and generalization of skills, the skills measure did not predict drug use
after treatment (Hawkins, Catalano, Gillmore, & Wells, 1989). Similarly, in a study of
treatment for alcohol dependence, Ehret, Ghaidarov and LaBrie (2013) found that among
those patients high in self-efficacy, behavioral strategies made no difference in terms of
alcohol use or consequences. That is, a threshold level of self-efficacy was sufficient to
account for improved outcomes regardless of the behavioral strategies used.
In part, our efforts to demonstrate “skillpower” as opposed to willpower may be limited by
our methods. This is especially true of our ability to measure coping behaviors, as we have
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mentioned elsewhere (Litt et al., 2012). Retrospective measures of coping behaviors most
likely fail to capture the complexity of steps taken to reduce or eliminate substance use in
unexpected high-risk situations, and over time as attitudes change. A measurement strategy
that can highlight what people actually do differently on a momentary or daily basis will be
necessary to refine our understanding of behavior change in these patients. We believe that
daily monitoring (see Tennen, Affleck, Armeli, & Carney, 2000) and experience sampling
(see, e.g., Litt, Kadden, & Kabela-Cormier, 2009) procedures hold promise to shed light on
these behavior change processes.

Author Manuscript

Another limitation of approaches like those used here is that they assume a static, stepwise
process of change, such that self-efficacy at time 1 should drive coping measured at time 2.
Although we would expect such a sequence to occur, the processes are probably quite
dynamic, and do not wait 3 or 6 months for us to measure them. It is likely that both selfefficacy and the use of coping skills change on a daily basis, and that while increased
confidence should breed greater perseverance at coping, successful coping most likely also
improves confidence.
The recursive effects of self-efficacy, mediators, and outcomes is mitigated to some extent
in the present study by our use of baseline-value covariates for the independent variable selfefficacy and for the mediator variables, and by the use of outcomes that were measured 4
months after the mediators were assessed. The effects predicting the 8–9 month outcomes
represent treatment period-related changes, and thus some temporal causality was preserved.
That is, change during the treatment period predicted outcomes at extended follow-up. This
was a strength of the present study.

Author Manuscript

As noted in our introduction, Marlatt was a strong believer in “skillpower;” the notion that
behavior change results from the acquisition of skills to reduce substance use and resist
relapse. In his model, self-efficacy is a cognitive condition that enables coping skills
acquisition and use. The fact that in a number of studies self-efficacy appears to operate
largely without the need for coping skills is a problem for our models of behavior change.
The results presented here, as limited as they are, nevertheless indicate that attention to
coping skills and to reducing emotional distress may be useful strategies in treatment of
marijuana use disorders. But these results also indicate that we should be searching for those
additional variables that mediate the effects of self-efficacy. We need to better understand
what people are actually doing differently as a result of being more confident.
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Figure 1.

Structural representation of the mediation design. The effect of self-efficacy on the outcome
variables through the mediators is given by c′. Both the independent variable and the
mediator variable are adjusted for baseline levels. Marij Self-Efficacy=Marijuana abstinence
self-efficacy score; CSS=Coping Strategies Scale score; BDI=Beck Depression Inventory
score; BSI=Brief Symptom Inventory score; ASIPsych=ASI Psychiatric Severity subscale
score.
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Figure 2.
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Marijuana-related dependent variables plotted by Trial and by self-efficacy level over time.
Self-efficacy level was determined separately for each trial. In each of the panels data for
Trial 1 were not collected for time periods Posttreatment (2months) or 11 months, and
therefore no data points are depicted for Trial 1 at those time points.
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Background Characteristics of Samples Used in Analyses.
Variable

Trial

Sex (% Male)

MTP (n=450)

MTP 2 (n=238)

MTP3 (n=213)

Total (N=901)

Mean (SD) or %

Mean (SD) or %

Mean (SD) or %

Mean (SD) or %

70.6

68.1

69.4

32.84 (9.60)

32.72 (10.06)

34.43 (9.25)

69.3
36.08* (8.34)

Age (Years)
Married or Cohabitating (%)

40.2

39.9

35.2

39.0

Employed Full or Part Time (%)

83.1*

73.5

75.6

78.8

12.95 (1.79)

13.17 (2.17)

13.55 (2.09)

14.04* (2.07)

Education (Years)
Ethnicity (%)

Author Manuscript

White

70.1

60.4

67.3

66.9

African American

12.1

18.8

12.1

13.9

Hispanic

17.3

15.0

17.3

16.7

Other

0.4

5.8

.3.

2.6

.11 (.15)

.10 (.17)

.11 (.16)

Proportion Days Abstinent (Baseline)

.12 (.16)

Note:
*

MTP > MTP2, MTP3 p < .05.
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−0.177
−0.001

BSIb
ASI Psych

0.000

0.030

0.122

0.001

0.000

0.028

0.009

0.001

0.000

0.028

0.013

0.001

0.501

14.86***

−0.999

12.47***

0.054
5.696

−5.28***
−4.06***

0.183

0.105

−3.17***

−6.00***

0.002

−6.24***

0.002

0.072

−4.40***

−7.56***

0.000

−0.005

−6.25***

−2.18*

0.084

13.66***

1.738

0.192

.0536

0.633

0.802

0.010

0.272

0.224

0.079

0.001

0.003

0.027

se

Coeff

se

t

B Path

A Path

3.28**

2.81**

3.42***

−1.58

0.13

0.20

0.06

2.09*

0.92

0.23

−2.08*

3.09**

t

−0.0061

−0.0096

−0.0134

−0.0091

−0.0001

−0.0004

−0.0001

0.0037

−0.0001

0.0001

0.0002

0.0007

Coeff

0.0026

0.0041

0.0050

0.0057

0.0007

0.0021

0.0018

0.0022

0.0001

0.0002

0.0001

0.0003

se

z

−2.50*

−2.50*

−2.94**

−1.56

−0.13

−0.20

−0.06

2.07*

−0.88

−0.23

2.42*

3.01**

Indirect Effect

−0.0128

−0.184

−0.2300

−0.0210

−0.0016

−0.0044

−0.0037

0.0005

−0.0003

−0.0005

0.0001

0.0003

Lower 95%

−0.0019

−0.026

−0.0030

0.0014

0.0011

0.0039

0.0034

0.0081

0.0001

0.0003

0.0004

0.0012

Upper 95%

7.9

14.2

18.5

7.3

2.3

11.3

% Total Effect

425

328

377

547

752

352

548

549

424

374

410

583

N
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p < .001

***

p < .01;

**

p < .05;

BSI only used in Trials 2 and 3

*

b

BDI only used in Trial 1

a

Note. A path = path from independent variable (self-efficacy) to mediator variable; B path = path from mediator variable to dependent variable; N = number of observations in analysis; Coeff =
unstandardized coefficient; se = standard error; % Total Effect= Percent of Total Effect Mediated by Variable (for significant mediators only); PDA=Proportion Days Abstinent; 4–5 Mo= Months 4 to 5
after baseline; MPS= Marijuana Problems Scale score; CSS=Coping Strategies Scale total score; BDI=Beck Depression Inventory score; BSI=Brief Symptom Inventory total score; ASI Alc= Addiction
Severity Index Alcohol Severity score; ASI Psych= Addiction Severity Index Psychiatric Severity score.

−0.073

BDIa

8–9 Mo

−0.001

ASI Psych
0.009

−0.177

BSIb

CSS

−0.065

BDIa

8–9 Mo

MPS

0.009

−0.001

ASI Psych
CSS

−0.177

BSIb

Abstinence

−0.029

0.009

Coeff

BDIa

CSS

PDA

8–9 Mo

Mediator

Dependent Variable

Results of Analyses of Mediation of Self-Efficacy Effects on Marijuana-Related Dependent Variables.
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−0.071

BDIa
ASI Psych

MPS

8–9 Mo

0.000

0.012

0.010

0.001

0.175
0.949

−2.91**

−0.100

−5.84***

−6.85***

0.070

9.60***

2.170

0.063

0.003

0.033

se

Coeff

se

t

B Path

A Path

0.44

2.79**

−0.37

2.09*

t

−0.0010

−0.0124

−0.0001

0.0005

Coeff

0.0026

0.0055

−0.3600

0.0003

se

Indirect Effect

−0.41

−2.49*

0.72

2.03*

z

−0.0070

−0.0232

−0.0004

0.0001

Lower 95%

0.0035

−0.0010

0.0003

0.0011

Upper 95%

17.0

8.3

% Total Effect

377

506

N

p < .001

***

p < .01;

p < .05;

**

*

BDI only used in Trial 1

a

Note. A path = path from independent variable (self-efficacy) to mediator variable; B path = path from mediator variable to dependent variable; N = number of observations in analysis; Coeff =
unstandardized coefficient; se = standard error; % Total Effect= Percent of Total Effect Mediated by Variables; PDA=Proportion Days Abstinent; 4–5 Mo= Months 4 to 5 after baseline; MPS= Marijuana
Problems Scale score; CSS=Coping Strategies Scale total score; BDI=Beck Depression Inventory score; BSI=Brief Symptom Inventory total score; ASI Alc= Addiction Severity Index Alcohol Severity
score; ASI Psych= Addiction Severity Index Psychiatric Severity score.

−0.001

−0.069

0.008

BDIa

CSS

PDA

Coeff

8–9 Mo

Mediator

Dependent Variable

Results of Analyses of Multiple Mediation of Self-Efficacy Effects on PDA and MPS Outcomes.
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